Former Interim Chief Financial Officer · TENAX THERAPEUTICS, INC. (TENX)

Lawrence Hoffman

FY2024 is the first fiscal year CompBrief holds for Lawrence Hoffman as a named executive officer of TENAX THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$297,019

Salary $0Stock awards $0

3rd of 3 named executive officers at Tenax Therapeutics by FY2024 total.

3 named officers on file for TENAX THERAPEUTICS, FY2024

Lawrence Hoffman’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how TENAX THERAPEUTICS’s whole pay program stands against its peers

  • TENAX THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TENX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Lawrence Hoffman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Lawrence Hoffman compensation by year

TENAX THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as TENAX THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$0
Bonus$0
Stock awards$0
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$297,019
Total$297,019

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TENAX THERAPEUTICS, INC. DEF 14A filed April 25, 2025, accession 0000950170-25-058329, and prior-year filings. Open the filing on EDGAR.

How this page was built: the TENAX THERAPEUTICS, INC. filed document, accession 0000950170-25-058329. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

TENAX THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Christopher GiordanoPresident and Chief Executive Officer$7,403,591
Stuart RichChief Medical Officer$3,138,044
Lawrence Hoffman · this pageFormer Interim Chief Financial Officer$297,019

The full TENAX THERAPEUTICS compensation record

free company brief

This page is one person within TENAX THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TENAX THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Lawrence Hoffman's compensation dossier · One-time report. No refunds.